0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
Published April 29, 2015 · Recall initiated: January 20, 2015
Summary
FDA records drug Class I recall D-0969-2015, published April 29, 2015 and initiated January 20, 2015. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 661,128 containers; Lot: Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, RxMay 31, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
- FDASymbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List numberNovember 16, 2016
- FDARose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped strip (NDCApril 29, 2015
- FDA4-Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
Questions about this recall
Was 0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02 recalled?
Yes. FDA published recall D-0969-2015 on April 29, 2015. Reported hazard: Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release